{"id":151541,"date":"2022-11-30T17:23:23","date_gmt":"2022-11-30T23:23:23","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2022\/11\/alzheimers-breakthrough-could-be-beginning-of-the-end-drug-study"},"modified":"2022-11-30T17:23:23","modified_gmt":"2022-11-30T23:23:23","slug":"alzheimers-breakthrough-could-be-beginning-of-the-end-drug-study","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2022\/11\/alzheimers-breakthrough-could-be-beginning-of-the-end-drug-study","title":{"rendered":"Alzheimer\u2019s breakthrough could be \u2018beginning of the end\u2019: drug study"},"content":{"rendered":"<p><a class=\"aligncenter blog-photo\" href=\"https:\/\/lifeboat.com\/blog.images\/alzheimers-breakthrough-could-be-beginning-of-the-end-drug-study2.jpg\"><\/a><\/p>\n<p>Alzheimer\u2019s disease could soon be a distant memory.<\/p>\n<p>A revolutionary <a href=\"https:\/\/nypost.com\/2022\/09\/28\/new-alzheimers-drug-lecanemab-slows-disease-study\/\">new Alzheimer\u2019s drug named lecanemab<\/a> could mark a major breakthrough in the decades-long battle against the neurological disorder, according to eye-opening Phase 3 trials. The potentially game-changing dry runs transpired in May 2021, but the results were only published Tuesday in the <a href=\"https:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMoa2212948\" target=\"_blank\" rel=\"noreferrer noopener\">New England Journal of Medicine<\/a>.<\/p>\n<p>\u201cThis first step is the hardest; I truly believe it represents the beginning of the end,\u201d <a href=\"https:\/\/www.dailymail.co.uk\/health\/article-11484039\/New-Alzheimer-s-drug-hailed-beginning-end-search-treatment.html\" target=\"_blank\" rel=\"noreferrer noopener\">said Professor John Hardy<\/a>, group leader at UK Dementia Research Institute at the University College London, describing the promising findings.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Alzheimer\u2019s disease could soon be a distant memory. A revolutionary new Alzheimer\u2019s drug named lecanemab could mark a major breakthrough in the decades-long battle against the neurological disorder, according to eye-opening Phase 3 trials. The potentially game-changing dry runs transpired in May 2021, but the results were only published Tuesday in the New England Journal [\u2026]<\/p>\n","protected":false},"author":511,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11,47],"tags":[],"class_list":["post-151541","post","type-post","status-publish","format-standard","hentry","category-biotech-medical","category-neuroscience"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/151541","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/511"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=151541"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/151541\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=151541"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=151541"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=151541"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}